From lymphopenia to restoration: IL-7 immunotherapy for lymphocyte recovery in glioblastoma

Joonseok Kim, Haeyoun Choi, Sin Soo Jeun, Stephen Ahn

Research output: Contribution to journalReview articlepeer-review

Abstract

Glioblastoma, the most prevalent malignant primary brain tumor, presents substantial treatment challenges because of its inherent aggressiveness and limited therapeutic options. Lymphopenia, defined as reduced peripheral blood lymphocyte count, commonly occurs as a consequence of the disease and its treatment. Recent studies have associated lymphopenia with a poor prognosis. Factors that contribute to lymphopenia include radiotherapy, chemotherapy, and the tumor itself. Patients who are female, older, using dexamethasone, or receiving higher doses of radiation therapy are particularly vulnerable to this condition. Several preclinical studies have explored the use of interleukin-7, a crucial cytokine for lymphocyte homeostasis, to restore lymphocyte counts and potentially rebuild the immune system to combat glioblastoma cells. With the development of recombinant interleukin-7 for prolonged activity in the body, various clinical trials are underway to explore this treatment in patients with glioblastoma. Our study provides a comprehensive summary of the incidence of lymphopenia, its potential biological background, and the associated clinical risk factors. Furthermore, we reviewed several clinical trials using IL-7 cytokine therapy in glioblastoma patients. We propose IL-7 as a promising immunotherapeutic strategy for glioblastoma treatment. We are optimistic that our study will enhance understanding of the complex interplay between lymphopenia and glioblastoma and will pave the way for the development of more effective treatment modalities.

Original languageEnglish
Article number216714
JournalCancer Letters
Volume588
DOIs
StatePublished - 28 Apr 2024

Bibliographical note

Publisher Copyright:
© 2024 Elsevier B.V.

Keywords

  • Glioblastoma
  • Immunotherapy
  • Interleukin-7
  • Lymphopenia

Fingerprint

Dive into the research topics of 'From lymphopenia to restoration: IL-7 immunotherapy for lymphocyte recovery in glioblastoma'. Together they form a unique fingerprint.

Cite this